Madhya Bharat Agro targets 60-70% FY27 growth on new plants; capex overruns 40%
The fertilizer maker guided for more than 100% revenue growth in FY28 as twin Maharashtra plants come online, but flagged a ₹1,000+ crore capex bill, 40% above original estimate, compressing margins near-term.
What's new
- Guided 60-70% top-line growth in FY27 and more than 100% in FY28
- Commissioned 3,30,000 MT SSP plant in April 2026; DAP/NPK plant from October 2026
- Capex estimate raised to >₹1,000 cr from ₹700 cr, a 40% overrun
Why this matters
The guidance implies revenue could more than double in two years, a bold bet for a fertilizer company. But the 40% capex overrun weakens the narrative: at a debt/equity of 1.56, the balance sheet is already stretched. Core manufacturing margins held at 13-15%, yet consolidated margins fell to ~10% due to trading, meaning the growth must come from higher-margin NPK, not just volume.
What we're watching
- Execution ramp-up of the DAP/NPK plant from October 2026
- Whether cost overruns are one-off or signal weak project management
- How the product mix shifts away from trading toward manufacturing
The full read
Madhya Bharat Agro delivered a record FY26 (₹1,867 crore revenue and ₹150 crore PAT) but the real story is the ask. Management expects 60-70% top-line growth in FY27 and more than 100% in FY28, powered by two new Maharashtra plants: a 3,30,000 MT SSP facility already online and a DAP/NPK plant kicking off in October 2026. That would roughly triple revenue in two years. Yet the same call disclosed a 40% cost overrun on the expansion, pushing capex to over ₹1,000 crore from an earlier ₹700 crore. Core manufacturing margins held at 13-15%, but consolidated margins slipped to ~10% because of opportunistic trading. At a market cap of ₹4,968 crore and a trailing P/E of 33.1, the stock already prices in much of the growth. The open question is whether the cost overrun sours the returns on that ₹1,000 crore bet.
Questions answered
- How fast is Madhya Bharat Agro expected to grow revenue?
- Management guided 60-70% top-line growth in FY27 and more than 100% in FY28, driven by a 150% capacity expansion across Maharashtra.
- What caused the 40% capex overrun?
- The expansion capex estimate rose to over ₹1,000 crore from the earlier ₹700 crore. Management flagged the overrun during the call but did not detail specific reasons.
- Why did consolidated margins compress to 10%?
- Consolidated margins fell due to opportunistic trading activities. Core manufacturing margins remained stable at 13-15%.
- What are the key new plants and their timelines?
- A 3,30,000 MT SSP plant came online in April 2026, and a DAP/NPK plant is expected to start in October 2026.
- How does the SECI ammonia deal fit in?
- Green ammonia sourcing from SECI from FY29 onwards is meant as a hedge against volatile West Asia prices. It does not affect near-term margins.
- What is the current valuation of Madhya Bharat Agro?
- The stock trades at a trailing P/E of 33.1 with a market cap of ₹4,968 crore, reflecting high growth expectations.